Access to Vaccines Index webinar for investors – co hosted by PRI and ICCR

On Wednesday 31 May, the Interfaith Center on Corporate Responsibility (ICCR), the Principles for Responsible Investment (PRI) and the Access to Medicine Foundation, will co-host an investor webinar about the recently published Access to Vaccines Index. The focus will be on access to vaccines as a material issue for investors in pharmaceutical companies and how the Access to Vaccines Index can be used as a tool for change.

Participants will discuss why access to vaccines is a material issue for investors in pharmaceutical companies and how the Access to Vaccines Index can be used as a tool to improve the availability and affordability of vaccines in low- and middle-income countries.

Speakers include:

Jayasree K. Iyer – Executive Director, Access to Medicine Foundation
Lauren Compere – Managing Director and Director of Shareholder Engagement at Boston Common Asset Management; Board Member, ICCR
Jon Pender – Vice President, Government Affairs, GSK; and Guy Pickles –Senior Manager, Global Health, GSK Vaccines.
Hanneke Schuitemaker – Vice President, Head Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention (Johnson & Johnson)

The webinar will take place on Wednesday, 31 May at 10:00 EDT/16:00 CEST and will be moderated by Alison Biscoe from PRI. If you have questions for the speakers, you can send them in advance to Alison.Biscoe@unpri.org

You can register for the webinar here.

The Access to Vaccines Index covers:

8 companies (Daiichi Sankyo, GSK, Johnson & Johnson, Merck & Co., Inc., Pfizer, Sanofi, Serum Institute of India and Takeda);
3 areas of corporate behaviour (research & development; pricing & registration; and manufacturing & supply);
69 diseases with the highest priority for improving access to immunisation (including pneumococcal disease, meningococcal disease, seasonal influenza, polio and Ebola).